# Diabetes Follow-up Consultation
**Date**: January 15, 2024  
**Patient**: John Doe  
**Provider**: Dr. Sarah Johnson

## Chief Complaint
Follow-up for Type 2 Diabetes Mellitus and medication adjustment.

## History of Present Illness
Patient reports good compliance with current medication regimen of Metformin 1000mg twice daily. However, recent home glucose monitoring shows fasting blood glucose levels ranging from 150-180 mg/dL. Patient admits to dietary indiscretions during the holiday season. No episodes of hypoglycemia reported. Mild numbness in bilateral feet noted over the past month.

## Physical Examination
- **Vital Signs**: BP 138/88, HR 76, Weight 198 lbs (up 5 lbs from last visit)
- **HEENT**: Fundoscopic exam reveals mild diabetic retinopathy
- **Cardiovascular**: Regular rate and rhythm, no murmurs
- **Extremities**: Diminished pedal pulses bilaterally, decreased sensation to monofilament testing on plantar surfaces
- **Skin**: Acanthosis nigricans noted on posterior neck

## Laboratory Results
- **HbA1c**: 8.2% (target <7%)
- **Fasting Glucose**: 165 mg/dL
- **Lipid Panel**: 
  - Total Cholesterol: 220 mg/dL
  - LDL: 140 mg/dL
  - HDL: 38 mg/dL
  - Triglycerides: 210 mg/dL
- **Kidney Function**:
  - Creatinine: 1.2 mg/dL
  - eGFR: 72 mL/min/1.73mÂ²
  - Urine Albumin/Creatinine Ratio: 45 mg/g (microalbuminuria)

## Assessment
1. Type 2 Diabetes Mellitus, inadequately controlled
2. Diabetic peripheral neuropathy, early stage
3. Diabetic retinopathy, mild non-proliferative
4. Hypertension, stage 1
5. Dyslipidemia
6. Diabetic nephropathy, stage 2 (microalbuminuria)

## Plan
1. **Medications**:
   - Continue Metformin 1000mg PO BID
   - Add Jardiance (empagliflozin) 10mg PO daily
   - Start Atorvastatin 40mg PO daily for dyslipidemia
   - Add Lisinopril 10mg PO daily for BP control and renal protection
   - Prescribe Gabapentin 300mg PO TID for neuropathic pain

2. **Lifestyle Modifications**:
   - Referral to diabetes educator and nutritionist
   - Target weight loss of 10% body weight
   - Exercise: 150 minutes moderate intensity per week

3. **Monitoring**:
   - Recheck HbA1c in 3 months
   - Daily home glucose monitoring
   - Annual diabetic eye exam
   - Podiatry referral for foot care

4. **Follow-up**: Return in 3 months or sooner if hypoglycemia occurs